Narusheniya protsessov mikrotsirkulyatsii v kozhe pri zabolevaniyakh perifericheskogo sosudistogo rusla


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The skin is the most affordable and convenient objective for non-invasive study of microcirculation in humans. The development of modern technology has led to a number of new and promising methods for noninvasive assessment of microcirculatory blood flow in humans - laser Doppler flowmetry (LDF), computer capillaroscopy (CCS), high-frequency Doppler ultrasound, etc. Data from LDF and CCF suggest the following: microcirculation of the skin can reflect the state of microcirculatory processes in other organs and systems. The assessment of microcirculatory blood flow in the skin of the lower extremities, susceptible to both arterial and venous circulation disorders are of particularly interest. Actovegin is one of the drugs, which allow to compensate the disturbance of microcirculation in vascular diseases of lower limbs of different etiology.

全文:

受限制的访问

参考

  1. Куприянов В.В., Караганов Я.Л., Козлов В.И. Микроциркуляторное русло. М., 1975. 216 с
  2. Чернух А.М., Александров П.Н., Алексеев О.В. Микроциркуляция. М., 1975. 456 с.
  3. Гайтон А.К., Холл Д.Э. Медицинская физиология. Пер. с англ. / Под ред. В.И. Кобрина. М., 2008. 1296 с.
  4. Caro CG, Pedly TJ, Schroter RC, Seed WA. The mechanics of the circulation. Cambridge: University Press 2012;524.
  5. Джонсон П. Периферическое кровообращение. М., 1982. 440 с.
  6. Braverman IM. The cutaneous microcirculation: ultrastructure and microanatomical organization. Microcirculation 1997;4(3):329-40.
  7. Rossi M, Taddei S, Fabbri A, et al. Cutaneous vasodilation to acetylcholine in patients with essential hypertension. J Cardiovasc Pharmacol 1997;29:406-11.
  8. Shamin-Uzzaman QA, Pfenninger D, Kehrer C, et al. Altered cutaneous microvascular responses to reactive hyperemia in coronary artery disease: a comparative study with conduit vessel responses. Clin Sci 2002;103:267-73.
  9. Stewart J, Kohen A, Brouder D, et al. Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. Am J Physiol Heart Circ Physiol 2004;287:2687-96.
  10. Holovatz LA, Thompson-Torgerson CS, Kenney WL. The human cutaneous circulation as model of generalized microvascular function. J Appl Physiol 2008;105:370-72.
  11. Dubiel M, Krolczyk J, Gasowski J, Grodzicki T. Skin microcirculation and echocardiographic and biochemical indices of left ventricular dysfunction in non-diabetic patients with heart failure. J Cardiology 2011;18(3):270-76.
  12. Hansell J, Henareh L, Agewall S, Norman M. Noninvasive assessment of endothelial function -relation between vasodilatory responses in skin microcirculation and brachial artery. Clin Physiol Funct Imaging 2004;24:317-22.
  13. Coulon P, Constsns J, Gosse P. Impairment of skin blood flow during post-occlusive reactive hyperhemy assessed by laser Doppler flowmetry correlates with renal resistive index. J Human Hypertension 2012;26:56-63.
  14. Sieg-Dobrescu D, Burnier M, Hayoz D, Brunner H-R, Waeber B. The return of increased blood pressure after discontinuation of antihypertensive treatment is associated with an impaired post-ischemic skin blood flow response. J Hypertension 2001;19:1387-82.
  15. Haak E, Abletshauser C, Weber S, et al. Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia. Atheroscl 2001;155:395-401.
  16. Vuilleumitr P, Decosterd D, Maillard M, et al. Postischemic forearm skin reactive hyperemia is related to cardiovascular risk factors in a healthy female population. J Hypertension 2002;20:1753-57.
  17. Binggeli C, Spieker LE, Corti R, et al. Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic parients. J Am Coll Cardiol 2003;42:71-7.
  18. Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur J Cardiovasc Preven Rehabil 2011;18 (6):775-89.
  19. Vanhoutte P.M. Endothelial dysfunction and atherosclerosis. Eur Heart J 1997;18(Suppl. E):19-29.
  20. Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol 2009;196:193-222.
  21. de Graaff JC, Ubbink DT, van der Spruit JA, et al. Influence of peripheral arterial disease on capillary pressure in the foot. J Vasc Surg 2003;38(5):1067-74.
  22. Rossi M, Bertuglia S, Varanini M, et al. Generalised wavelet analysis of cutaneous flowmotion during post-occlusive reactive hyperemia in patients with peripheral arterial obstructive disease. Biomed Pharmacother 2005;59(5):233-39.
  23. Urbancic-Rovan V, Bernjak A, Stefanovska A, et al. Macro- and microcirculation in the lower extremities - possible relashionship. Diab Res Clin Pract 2006;73(2):166-73.
  24. Junger M, Frey-Schnewlin G, Bollinger A. Microvascular flow distribution and transcapillary diffusion at the forefoot in patients with peripheral ischemia. Int J Microcirc Clin Exp 1989;8(1):3-24.
  25. Langheinrich AC, Kampschulte M, Buch T, Bohle RM. Vasa vasorum and atherosclerosis - Quid novi? Thromb Haemost 2007;97:872-79.
  26. Mulligan-Kehoe MJ. The vasa vasorum in diseased and nondiseased arteries. Am J Physiol Heart Circ Physiol 2010;298:295-305.
  27. Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries - a possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984;310:175-77.
  28. Кротовский Г.С., Зудин А.М., Мир-Касимов М.Р. Изучение пааметров микроциркуляции методом лазерной допплерфлоуметрии (ЛДФ) убольных хронической критической ишемией на фоне нереконструируемого хронического окклюзионного заболевания артерий нижних конечностей (ХОЗАНК). Метод Флоуметр 1999. № 3. С. 47-59.
  29. Binggeli C, Spieker LE, Corti R, et al. Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic parients. J Am Coll Cardiol 2003;42:71-7.
  30. Genoud M, Wietlisbach V, Feihl F, et al. Surrogate markers for atherosclerosis in overweight subjects with atherogenic dyslipidemia: the GEMS project. Angiology 2008;59(4):484-92.
  31. Khan F, Litchfield SJ, Stoebridge PA, Belch JJ. Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease. Vasc Med 1999;4: 233-38.
  32. Jagren C, Gazelius B, Ihrman-Sandal C, et al. Skin microvascular dilatation respons to ace-tylcholin and sodium nitroprussid in peripheral arterial disease. Clin Physiol & Func Imag 2002; 22: 370-74.
  33. Rossi M, Carpi A, DiMaria C, et al. Skin blood flowmotion and microvascular reactivity investigation in hypercholesterolemic patients without clinically manifest arterial diseases. Physiol Res 2009;58:39-47.
  34. Caspary LA, Creutzig A, Alexander K. Orthostatic vasoconstrictor response in patients with occlusive arterial disease assessed by laser Doppler flux and transcutaneous oximetry. Angiol 1996;47(2):165-73.
  35. Cisek PL, Eze AR, Comerota AJ, et al. Microcirculatory compensation to progressive atherosclerotic disease. Ann Vasc Surg 1997;11(1):49-53.
  36. Otah KE, Otah E, Clark LT, Salifu MO. Relationship of lower extremity skin blood flow to the ankle brachial index in patients with peripheral arterial disease and normal volunteers. Int J Cardiol 2005;103(1):41-6.
  37. Lefrandt JD, Bosma E, Oomen PHN, et al. Sympathetic mediated vasomotion and capillary permeability in diabetic patients with peripheral neuropathy. Diebetol 2003;46:40-7.
  38. Oomen PHN, Jager J, Hoogenberg K, et al. Capillary permeability is increased in normo-and microalbuminuric Type 1 diabetic patients: amelioration by ACE-ingibition. Eur J Clin Invest 1999;29:1035-40.
  39. Vervoort G, Lutterman JA., Smits P, Berden JH, Wetzels JF. Transcapillary escape rate of albumin is increased and related to haemodynamic changes in normo-albuminuric type 1 diabetic patients. J Hypertens 1999;17:1911-16.
  40. Stanaberry KB, Hill M.A, Shapiro SA, et al. Impairment of peripheral blood flow responses in diabetes resembles an enhanced aging effect. Diabetes Care 1997;20:1711-16.
  41. Bornmyr S, Castenfors J, Svensson H, et al. Abnormal vasoreaction to arousal stimuli - an early sing of diabetic sympathetic neuropathy by laser Doppler flowmetry. J Clin Neurophysiol 2000;17:419-25.
  42. Крупаткин А.И. Клиническая нейроангиофизиология конечностей (периваскулярная иннервация и нервная трофика). М., 2003. 328 с.
  43. Landis ЕМ. Factors controlling the movement of fluid through the human capillary wall. YaleJ Biol Med 1933;5(3):201 -25.
  44. Speiser DE, Bollinger A. Microangiopathy in mild chronic venous incompetence (CVI): morphological alterations and increased transcapillary diffusion detected by fluorescence videomicroscopy. Int J Microcirc Clin Exp 1991; 10(1 ):55-66.
  45. Franzeck UK, Haselbach P, Speiser D, Bollinger A. Microangiopathy of cutaneous blood and lym phatic capillaries in chronic venous insufficiency (CVI). YaleJ Biol Med 1993;66:37-46.
  46. Jiinger M, Steins A, Hahn M, Hdfner HM. Microcirculatory dysfunction in chronic venous insufficiency (CVI). Microcirc 2000;7:3-12.
  47. Лосев P.3., Буров Ю.А., Микульская Е.Г., Якушева Е.А. Оценка состояния микроциркуляции у пожилых больных с трофическими венозными язвами // Ангиол. и сосудистая хирургия 2005. № 1. С. 65-74.
  48. Reikeras О, Sorlie D. The significance of arteriovenous shunting for the development of varicose veins. Acta ChirScand 1983;I49(5):479-81.
  49. Ванков B.H. Строение вен. М., 1974. 206 с.
  50. Buchmayer F, Pleiner J, Elmlinger MW, et ai. Actovegin®: a biological drug for more than 5 decades. Wien Med Wochensch 2011;161(3-4):80-8.
  51. Machicao F, Muresanu DF, Hunsberger H, et а!. Плейотропный нейропротективный и метаболический эффекты актовегина // Нервно-мышечные болезни 2012. № 4. С. 3-10.
  52. Кротовский Г.С., Зудин А.М., Учкин И.Г., и др. Медикаментозное лечение хронической критической ишемии нижних конечностей // РМЖ 2010. № 17. С. 1046-48.
  53. Зудин А.М., Учкин И.Г., Талов Н.А., Хмырова Е.В. Воздействие Актовегина на коллатеральную гемодинамику (по данным дуплексного сканирования) у пациентов с хронической ишемией нижних конечностей // РМЖ 2011. №32. С. 2044-48.
  54. Хисматова P.P., Трухова В.В., Макарова Н.Н., Гусева С.Л. Актовегин влечении трофических язв нижних конечностей венозной этиологии //РМЖ 2008. № 29. С. 2022-24.
  55. Мелешкевич Т.А., Лучина Е.И., Лукашова М.Е. Двойной эффект Актовегина в лечении поздних осложнений диабета // РМЖ 2011. № 13. С. 858-60.
  56. Федорович А.А., Рогоза А.Н., Канищева Е.М., Бойцов С.А. Влияние препарата Актовегин на метаболическую и вазомоторную функцию микрососудистого эндотелия кожи человека // Рацион, фармакотерапия в кардиологии 2010. № 1. С. 53-60.
  57. Fedorovich АА. Non-invasive evaluation of vasomotor and metabolic functions of microvascular endothelium in human skin. Microvasc Res 2012;84:86-93.
  58. Thorn CE, Kyte H, Slaff DW, Shore AC. An association between vasomotion and oxygen extraction. Am J Physiol Heart Circ Physiol 2011;301:442-49.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##